MedTrace Logo

TherApy in stabLe Coronary Artery dIsease Patients According to Clinical GuideliNes (ALIGN)

NCT04162561 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70

Last updated 2023-03-15

No results posted yet for this study

Summary

The aim of this prospective cohort study is to assess the quality of therapy in patients with stable ischemic heart disease (IHD) who had never applied for specialized medical care for the last 3 years and try to accord their treatment with current clinical guidelines.

Conditions

  • Stable Ischemic Heart Disease

Interventions

BEHAVIORAL

Patients with documented IHD

Assessment of patients' quality of life with the use of the Seattle Angina Questionnaire (SAQ), blood pressure levels (using the Korotkoff method, blood pressure is measured 3 times with 1-minute intervals on the hand with the higher blood pressure levels while sitting calm after a 5-minutes rest), laboratory methods (lipids, glycosylated hemoglobin levels), patients' adherence to treatment (original questionnaire), quality of patients' therapy taken at the time of visit, necessity of invasive coronary revascularization procedures (during all visits).

Sponsors & Collaborators

  • National Research Center for Preventive Medicine

    lead OTHER_GOV

Principal Investigators

  • Sergey Martsevich, PhD · National Research Center for Preventive Medicine

  • Ekaterina Zharkova, MD · National Research Center for Preventive Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-31
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04162561 on ClinicalTrials.gov